-
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS-2023-1 Phase II: Adaptation of CRISPR-Based In Vitro Diagnostics for Rapid Detection of Select Eukaryotic Pathogens (Topic 119).
Date: February 4, 2025.
Time: 1:00 p.m. to 4:00 p.m.
Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Video Assisted Meeting).
Agenda: To review and evaluate contract proposals.
Contact Person: Mario Cerritelli, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious ( print page 2711) Diseases, National Institutes of Health, 5601 Fishers Lane, MSC-9823, Rockville, MD 20892, 240-669-5199, cerritem@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: January 6, 2025.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-00456 Filed 1-10-25; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 01/13/2025
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2025-00456
- Dates:
- February 4, 2025.
- Pages:
- 2710-2711 (2 pages)
- PDF File:
- 2025-00456.pdf